Rifampicin
[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate
Molecular Identity
Rifampicin
[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate
PubChem CID: 135398735
Rifampin can cause developmental toxicity and female reproductive toxicity according to state or federal government labeling requirements.
2D Structure
Properties
C43H58N4O12
Molecular Formula
822.90
Molecular Weight
g/mol
822.4051
Exact Mass
Da
4.9
XLogP
Drug-like (Lipinski: < 5)
220
TPSA
May have limited oral absorption
6
H-Bond Donors
15
H-Bond Acceptors
1620
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Rifampicinrifampin13292-46-1RifaldazineRifamycin AMPRifaprodinRifoldinRifaRifampicinumRiforalAbrifamEremfatL-5103 LepetitRifaldinRifoldine
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Rifampicin
Loading drug network...